Bring greater clarity to every facet of your plan
Tough decisions are much easier to support when they are backed by empirical evidence. Whether it’s winning the next big pitch, deciding which opportunity to fund, or determining where to focus your strategy, the more data-driven your decisions, the more likely you are to succeed.
That’s why Prism leverages the unprecedented power of our Healthcare Map to generate highly-segmented cohorts – from a broad spectrum of disease areas, treatment types, and HCP behaviors – to help you discover just the right insight.
The Prism Advantage:
Leverage insights from real-world outcomes, market knowledge, and product surveillance
Demonstrate value to key decision makers with market-based insights, real-world evidence, and value-based outcomes
Identify market potential, patient density, and optimal sites of care to achieve your goals
Recognize trends, patterns, and signals that elude other solutions
Infuse insights directly into existing workflows, studies, and products when paired with Sentinel
Prism in Action:
HEOR/RWE studiesMonitor patient outcomes over time. See which treatment plans are chosen and measure their effectiveness
Cohort AnalysisCompare comorbidities, treatment patterns, disease densities, and other attributes to support clinical trial recruitment
Drug DevelopmentUse market-sizing and assessment features to prioritize indications and determine viability for new lines of therapy
Provider BenchmarkingRun analyses of HCP activity based on multiple parameters, including patient outcomes, treatment decisions, and geographic regions
Commercial AnalyticsView patient flow(s) through the entire healthcare system to gain a better understanding of diagnostic and treatment patterns
Real Results That Make a Real Difference
Prism enables us to conduct more accurate studies. We can now see the true outcomes of patients over time and know how effective treatments were.
Prism has become a key part of our R&D strategy. We now have access to current, detailed patient-level information to help us prioritize our funding.
The insights we’re able to obtain from the data in Prism has enabled us to make better decisions. We can now run reliable analyses on everything we need, from treatment decisions and outcomes to geography.